Jespersen J, Sidelmann J
Thromb Haemost. 1983 Aug 30;50(2):581-5.
Determinations of alpha 2-antiplasmin and alpha 2-macroglobulin were made in plasma samples collected during one normal or hormone induced cycle in 15 normal women and 11 women using oral contraceptives containing 30 micrograms ethinyl oestradiol and 150 micrograms levo-norgestrel. The immediate plasmin inhibition test for determination of alpha 2-antiplasmin was modified for application on a centrifugal analyser using the chromogenic peptide substrate Chromozym PL. alpha 2-Macroglobulin concentration was determined by radial-immunodiffusion. There were no differences between the two groups in the mean concentrations of alpha 2-antiplasmin and alpha 2-macroglobulin, but during the cycle a slight, and statistically significant fall occurred in the alpha 2-antiplasmin concentration in both groups, while the fluctuations of alpha 2-macroglobulin were small and insignificant. Distinctly individual levels of both inhibitors were found to exist. The variations in these during the periods of the cycle fluctuated within a much narrower range than the variation of the total average. The results stress the importance of determining the fluctuations in individual levels in longitudinal studies. These findings exclude variations in the concentrations of these inhibitors as possible sources of a change in the antithrombotic potential caused by oral contraceptives.
对15名正常女性和11名服用含30微克炔雌醇和150微克左炔诺孕酮口服避孕药的女性,在一个正常或激素诱导周期内采集的血浆样本进行了α2 - 抗纤溶酶和α2 - 巨球蛋白的测定。用于测定α2 - 抗纤溶酶的直接纤溶酶抑制试验经改良后,使用发色肽底物Chromozym PL在离心分析仪上进行。α2 - 巨球蛋白浓度通过放射免疫扩散法测定。两组之间α2 - 抗纤溶酶和α2 - 巨球蛋白的平均浓度无差异,但在周期中两组的α2 - 抗纤溶酶浓度均出现轻微且具有统计学意义的下降,而α2 - 巨球蛋白的波动较小且无统计学意义。发现两种抑制剂存在明显的个体水平差异。在周期各阶段,这些差异的波动范围比总平均值的变化范围窄得多。结果强调了在纵向研究中测定个体水平波动的重要性。这些发现排除了这些抑制剂浓度变化作为口服避孕药引起抗血栓形成潜能改变的可能来源。